
Regulation & policy


Dietary fiber designed to slow weight gain receives novel food approval
A new dietary fiber has received novel food approval after six years of regulatory uncertainty, marking the start of its journey to commercialization.


Growing demand for evidence-backed fiber drives Myota’s $4.5m funding round
Patented prebiotic fiber blend Myota has raised $4.5 million in a Series A round led by venture capital firm PeakBridge to expand its clinically validated prebiotic fibre business.

Cost analysis suggests probiotic use could have €10 billion impact
A 1% increase in probiotic use could have a €10 billion economic impact across Europe, according to a newly released socio-economic assessment (SEA) commissioned by IPA Europe.


Regulation replaces discovery as biggest challenge for microbial innovation, say experts
The future of microbial innovation will be defined less by the discovery of effective organisms and more by the ability to navigate increasingly complex regulatory frameworks.

Time for self-regulation: EHPM launches influencer marketing guidelines
The European Federation of Associations of Health Product Manufacturers (EHPM) has unveiled new guidance for influencers and food business operators working in the supplement sector.

EU greenlights The Protein Brewery’s Fermotein in first mycelium approval
Following a unanimous EU vote, the Dutch company is leveraging its five-year data exclusivity and low-cost fermentation to scale production of its mycoprotein globally.

Industry calls for digital-age update as Ireland health claims consultation nears deadline
The Food Safety Authority of Ireland (FSAI) is inviting feedback from Food Business Operators (FBOs) on draft guidance about the use of general, non-specific health claims on food products ahead of tomorrow’s deadline (June. 19).

Benicaros gains EFSA Novel Food approval and ‘competitive advantage’
The European Commission has authorized Ingredion’s recently acquired patented prebiotic carrot-fiber, Benicaros SF Pure (300 mg), as a Novel Food, allowing manufacturers to use it in food supplements across the EU.

International Probiotics Conference set to deliver unmissable insights from birth to spaceflight
A key forum for microbiome-focused scientists, researchers, and industry, arrives in Kraków, Poland, next week (June 22–24), to spotlight cutting‑edge discoveries, from next‑generation strains and longevity research to smart tech and spaceflight.


Across the Nutraverse: H&B in APAC, Garcinia in France, FTC vs Amare
Catch up with our weekly round-up of key news from across the Nutraverse.


Spinach extract one step closer to satiety health claim
Science-backed spinach extract Appethyl has taken a significant step towards health claim approval and is now available for acquisition by firms eager to compete in the GLP-1 market.

‘Unmatched’: Nutra Healthspan Summit returns for November 2026
Described by one attendee as “an event with wall-to-wall speakers who delivered insightful, topical, useable information”, the Nutra Healthspan Summit is returning to London for its 2nd edition with more high-level content and networking opportunities.






News in brief
Indian high court grants interim stay on ashwagandha leaf ban
The Karnataka High Court in Bangalore has temporarily stayed the Indian government’s restriction on the use of ashwagandha leaves issued last month after industry stakeholders challenged the rationale behind the blanket ban.

EC clarifies Novel Food status of concentrated olive extracts
The European Commission has updated its Novel Food Catalogue to clarify the regulatory status of olive-derived ingredients.

EFSA issues positive safety opinion on EffePharm’s NMN
The European Food Safety Authority (EFSA) has issued a positive safety opinion on EffePharm’s β-NMN (nicotinamide mononucleotide), moving the novel food within reach of EU approval.

Across the Nutraverse: India’s ashwagandha leaf ban, prebiotics in Canada, sports nutrition opportunity
Catch up with our weekly round-up of key news from across the Nutraverse.


Across the Nutraverse: Clinical trials for active women, Andrographis in Australia, MPL in the House
Catch up with our weekly round-up of key news from across the Nutraverse.



EU continues CBD scrutiny, rejecting 6 more novel food applications
The European Commission has terminated a backlog of cannabidiol (CBD) novel food applications for lack of data and non-compliance.

Across the Nutraverse: GOED unveils new database, Magtein in the UK, gut microbe and muscle strength
Catch up with our weekly round-up of key news from across the Nutraverse.

Magtein approved as a novel food in the UK, two years after EU approval
Magtein, a branded form of magnesium L-threonate, has been approved as a novel food in the UK by Food Standards Agency (FSA) and has secured a five-year data protection period.

New pharmacovigilance survey on natural health products to roll out globally
A new survey covering global pharmacovigilance approaches in the natural health products sector is launching soon and will be extended to over 200 industry organizations and regulatory bodies, including those in China, the United States, Europe and other...

‘No safe intake’ level for berberine: EFSA opens consultation
Experts have warned the future for berberine containing plants looks bleak after EFSA published a draft opinion questioning their safety, with a stakeholder consultation now open until May. 4.

Are the rules governing probiotics still built for a pre-microbiome era?
Europe is taking a cautious approach as it reassesses how probiotics and the microbiome should be addressed within food and health regulation, attendees heard at the recent IPA World Congress + IPA 2026 event.

Dsm-firmenich vs Mara Renewables patent dispute concludes in Court of Appeal
Dsm-firmenich and Mara Renewables Corporation have been denied their appeals in relation to a recent UK High Court battle over three claims of patent infringement.

World Customs Organization formally recognizes dietary supplements as a standalone category
Dietary supplements are set to be formally recognized as a distinct category in global trade for the first time, following a recent update to the Harmonized System by the World Customs Organization.

“Its moment has arrived”: Marula fruit ripe for global functional food success
The highly abundant South African polyphenol-rich marula fruit is being under-exploited by the functional food and supplements industry, according to the Marula Fruit Products Association.

Authorities play catch-up on caffeine energy pouch regulation
Highly caffeinated energy pouches currently exist in a regulatory grey area, with a patchwork of different rules beginning to emerge across European nations.

Longevity ingredients under the EU regulatory spotlight
When a health trend takes off, the nimble nutrition industry is adept at creating and marketing new products that fit consumers’ emerging demands. But with this can come a tendency to overlook the regulatory status of burgeoning ingredients.

Across the Nutraverse: FDA eyes GMP, GRAS, NDI updates; EFSA’s QPS list changes; NMN expansion Down Under
Catch up with our weekly round-up of key news from across the Nutraverse.

EFSA’s QPS update opens opportunities for microbial innovation
EFSA has published its scientific opinion on the safety of several microorganisms, confirming new microbes eligible for streamlined safety assessments.


Novel Foods: Major updates on botanical assessments
The European Commission (EC) has updated its Novel Food Catalogue, offering crucial clarification on the status of several traditional botanical ingredients.

Across the Nutraverse: Ginseng adulteration, EFSA’s DHA levels, ANH sues FDA, Aker’s India strategy
Catch up with our weekly round-up of key news from across the Nutraverse.

EFSA sets ‘conservative’ safe intake level for DHA
EFSA has published its scientific opinion on the safe level of supplemental docosahexaenoic acid (DHA) following concerns that sustained use could increase the risk of spontaneous bleeding.

Scott Bass launches life sciences strategy and dispute-resolution venture
Scott Bass is launching a new firm—Scott Bass Life Sciences LLC—focused on two core offerings: high level strategic guidance for the global self-care sector and a low-cost dispute resolution model designed specifically for life sciences companies.

Postbiotics, regulation and strain optimization to headline Probiota day two
Day two at the IPA World Congress + Probiota Dublin 2026 will see experts discuss regulatory updates, postbiotic science and strain-level innovation.
